BridgeMD
New treatment option for ICU Patients
Official title The Effect of a 6-month Dietitian-tailored Nutrition Intervention to Patients With Critical Illness (DETAIL)
ClinicalTrials.gov ID: NCT07149246
What this study is testing
- What it's testing
- This research project aims to study the effect of optimal and individualised nutrition to patients with critical illness during the intensive care unit (ICU) and hospital admission, and until six months after admission. The investigators want to describe and compare the usual care with a dietitian-tailored nutrition care.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients in intensive care who gives an informed consent and meet all of the following will be eligible:
- Admitted to the intensive care unit for \>48 hours.
- At least 18 years of age
- Have one or more organ system failure (respiratory,cardiovascular or renal) related to their acute illness defined as: a. PaO2/FiO2≤300 mm Hg) b...
- Permanent living address in Norway
You likely can't join if
- Patients will be excluded if:
- Death is imminent in the next 96 hours or there is a current treatment limitation in place or the patient is unlikely to survive to 180 days due to...
- Dialysis dependent chronic renal failure
- Suspected or known pregnancy
- Wheelchair user
- Cognitive impairment in which intervention is considered not appropriate
See the full eligibility criteria
- Patients in intensive care who gives an informed consent and meet all of the following will be eligible:
- Admitted to the intensive care unit for \>48 hours.
- At least 18 years of age
- Have one or more organ system failure (respiratory,cardiovascular or renal) related to their acute illness defined as: a. PaO2/FiO2≤300 mm Hg) b. Currently on one or more continuous inotrope/vasopressor infusion which...
- Permanent living address in Norway
- Patients will be excluded if:
- Death is imminent in the next 96 hours or there is a current treatment limitation in place or the patient is unlikely to survive to 180 days due to underlying/chronic illness
- Dialysis dependent chronic renal failure
- Suspected or known pregnancy
- Wheelchair user
- Cognitive impairment in which intervention is considered not appropriate
- Eating disorders -
The study team makes the final eligibility decision.
Where it's taking place
- Tromsø, Norway
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tromsø, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.